José A. Spoelstra

Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?

José A. Spoelstra, Ronald P. Stolk, Eibert R. Heerdink et al. · Pharmacoepidemiology and Drug Safety · 2003 · 45 citations · Full text

Medicine, Internal Medicine, Clinical Pharmacology +15

Antihypertensive drug therapy and the risk of lower extremity amputations in pharmacologically treated type 2 diabetes patients

Joëlle A. Erkens, Olaf H. Klungel, Ronald P. Stolk et al. · Pharmacoepidemiology and Drug Safety · 2004 · 41 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Antipsychotic Drugs May Worsen Metabolic Control in Type 2 Diabetes Mellitus

José A. Spoelstra, Ronald P. Stolk, Dan Cohen et al. · The Journal of Clinical Psychiatry · 2004 · 35 citations

Medicine, Internal Medicine, Pharmacology +16

Factors associated with switching from oral hypoglycaemic agents to insulin therapy.

José A. Spoelstra, Martine C. de Bruyne, Joëlle A. Erkens et al. · PubMed · 2002 · 17 citations

Medicine, Pharmacology, Pharmacotherapy +12

Initiation of glucose‐lowering therapy in Type 2 diabetes mellitus patients in general practice

José A. Spoelstra, Ronald P. Stolk, Olaf H. Klungel et al. · Diabetic Medicine · 2004 · 14 citations · Full text

Medicine, Endocrinology, Internal Medicine +13